FDC denies reports of stake sale

Posted By:
Subscribe to GoodReturns

 FDC denies reports of stake sale
FDC: Quotes, News
BSE 223.80BSE Quote0.5 (0.22%)
NSE 223.30NSE Quote0.1 (0.04%)
Pharma company, FDC strongly denied reports of a stake sale by the Chandavarkar family.

"The Chandavarkar family which is promoters of pharma firm FDC, plan to sell their 67% stake in the company. Buyout fund Carlyle had shown interest in buying the company and had even valued it at about Rs3,800 crore. But it is not known if a transaction will take place with the private equity fund," a media reported had stated.

"With reference to the news item appearing in a leading financial daily titled "Pharma Back on M&A Street, FDC Owners in Talks to Exit", FDC Ltd has clarified to BSE that the above news is completely false and baseless," FDC has clarified in statement to the exchange.

The FDC stock was last traded at Rs 97 on the National Stock Exchange, after hitting a 52-week high of Rs 105 earlier in the day.

GoodReturns.in

Read more about: fdc
Story first published: Monday, December 24, 2012, 13:02 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?